Cultivate(MD)

Cultivate(MD) is an early-stage medical device fund based in Grand Rapids, Michigan, with a clearly defined thesis around regenerative medicine, orthopedics, and surgical logistics. The portfolio includes Shoulder Innovations and Embody, both of which sit squarely within that orthopedic and tissue-repair lane. The fund is not an AI-focused investor; it is a domain-specialist device fund where the edge comes from understanding implant design, surgical workflow, and the orthopedic distribution landscape.

Cultivate(MD) writes $1M to $5M checks at Seed and Series A, which positions it to lead or co-lead small device rounds where capital efficiency matters. The Grand Rapids base reflects Michigan’s deep medical device ecosystem, but the fund deploys nationally rather than restricting itself geographically.

Founders should approach Cultivate(MD) when they are building an orthopedic implant, a regenerative medicine product, or a surgical-logistics tool with a credible 510(k) or De Novo path. Soft-tissue, sports medicine, and shoulder/spine adjacencies are particularly aligned. Cardiovascular, neurology, and digital health teams will not find the fit. Because the fund is sub-vertical-specific, expect partners who already know the competitive landscape and the surgeon-influencer networks; that means less education work for the founder but also less tolerance for unclear positioning. Bring a sharp surgical-customer story and a realistic regulatory timeline rather than a broad MedTech narrative.